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1 |  INTRODUCTION
Currently, a substantial amount of evidence confirms the 
importance of genetic contributions to mental illnesses. 
Heritability estimates for almost all psychiatric disorders are 
in the range of 0.30–0.80; 0.35 for major depressive disor-
der (MDD) (Otte et al., 2016), 0.75 for bipolar disorder (BD) 
(Sullivan, Daly, & O’Donovan, 2012), 0.40 for obsessive 
compulsive disorder (OCD) (Pauls, Abramovitch, Rauch, & 
Geller, 2014), 0.30–0.80 for anorexia nervosa (AN) (Shih & 
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Abstract
Background: The heritability of several psychiatric disorders is high, and specific 
at‐risk variants have been identified. Therefore, genetic counseling and genetic test-
ing can be prescribed to some psychiatric patients, but these services are not stand-
ardized for most of the population. The aims of the study were to gather opinions 
from mental health professionals and users regarding (a) the genetics of psychiatric 
disorders and (b) the usefulness of a genetic counseling unit in psychiatry.
Methods: The survey was conducted in the province of Tarragona (Spain), and we 
analyzed 152 valid questionnaires from professionals and 959 from users.
Results: Sixty‐one percent of professionals strongly believed that psychiatric disor-
ders have a genetic basis, and 59% rated a genetic counseling unit in psychiatry as 
very or extremely useful. However, only a few professionals reported that patients 
asked them about the genetics of their diseases (12%) or the possibility of transmit-
ting the disease to offspring (19%). Forty‐seven percent of users strongly believed 
that psychiatric disorders have a genetic basis, 30% responded that they talked with 
their families about the genetics of their diseases, and 43% were worried about trans-
mitting the disease to offspring; however, only 14% reported that their psychiatrist 
had talked to them about this topic. Remarkably, 80% of users would consider a 
genetic counseling unit very or extremely useful.
Conclusions: The present study showed that mental health professionals were more 
aware of the genetic basis of psychiatric disorders than users, and both considered the 
implementation of a genetic counseling service very useful.
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Woodside, 2016), 0.70–0.80 for attention‐deficit hyperac-
tivity disorder (ADHD) (Voeller, 2004), and 0.80 for both 
autism spectrum disorder (ASD) (Colvert et al., 2015) and 
schizophrenia (SCH) (Kahn et al., 2015). The rest of the vari-
ability is known to be caused by environmental factors, such 
as stressful life situations, brain damage, cannabis abuse, and 
childhood maltreatment (Schmitt, Malchow, Hasan, & Falkai, 
2014), and interactions between genes and the environment 
through epigenetic mechanisms. In fact, the presence of a 
psychiatric illness in a patient's biological relatives is a strong 
risk factor for many psychiatric disorders. Moreover, some 
genetic factors are shared between distinct psychiatric diag-
noses, suggesting a common genetic background (Smoller et 
al., 2013; Torres, Barbosa, & Maciel, 2016).
Both single nucleotide polymorphisms (SNPs) and copy 
number variants (CNVs) are implicated in the development 
of psychiatric disorders. Genome‐wide association studies 
have identified hundreds of SNPs with very small effects that 
confer a risk for a wide range of psychiatric disorders (Cross‐
Disorder Group of the Psychiatric Genomics Consortium, 
Ripke, Neale, Faraone, & Purcell, 2013). Regarding CNVs, 
compelling data suggest that a small number of recurrent de-
letions and duplications increase the risk of several neuro-
developmental disorders, including ASD, SCH, BD, seizure 
disorder, and intellectual disability (ID) (Jiang et al., 2014; 
Kirov et al., 2014). Interestingly, approximately 65% of the 
recurrent CNVs are de novo variants (Rees, Moskvina, Owen, 
O’Donovan, & Kirov, 2011), indicating that they are not in-
herited. Of these, 22q11.2del is the most prevalent CNV as-
sociated with SCH and ASD. Recently, both 22q11.2 deletion 
and duplication have been associated with an increased risk 
of any psychiatric disorder and with a highly increased risk of 
ID in a Danish nationwide, register‐based study (Hoeffding et 
al., 2017). In addition to SNPs and CNVs, rare coding vari-
ants (RCVs), which have an allele frequency <1:1,000 and 
affect a single or a few nucleotides, have been demonstrated 
to exert considerable effects on the risk for psychiatric disor-
ders (O’Donovan & Owen, 2016).
Genetic counseling is the process of advising individuals 
and families affected by or at risk of genetic disorders to help 
them understand and adapt to the medical, psychological, and 
familial implications of genetic contributions to disease (Resta 
et al., 2006), and it is neither synonymous with nor depen-
dent on genetic testing (Moldovan, Pintea, & Austin, 2017). 
Genetic testing is a part of genetic counseling when a genetic 
test is available to detect a DNA alteration, such as the 22q11.2 
CNV; however, this practice is currently very limited in men-
tal health settings (Moldovan et al., 2017). A large component 
of genetic counseling is informing affected subjects about the 
risk of developing or transmitting a disease and the associated 
consequences when subjects plan to have children. However, 
part of genetic counseling in psychiatry aims to help affected 
individuals adapt to mental illness, understand the etiology 
of their disease, and increase empowerment and positive 
self‐identity (Costain & Bassett, 2012; Hippman et al., 2016; 
Inglis, Koehn, Mcgillivray, Stewart, & Austin, 2015).
Knowledge of the genetics of psychiatric diseases may 
allow genetic counseling for symptomatic and nonsymptom-
atic patients; however, genetic counseling is currently not 
broadly offered to psychiatric patients and families in most 
developed countries (Moldovan et al., 2017). The genetic con-
tribution to psychiatric disorders is not more complex or less 
significant than the genetic contribution to other complex dis-
eases for which genetic counseling is traditionally offered. For 
example, at least in Europe and specifically in Spain, the pub-
lic health system offers genetic testing and genetic counseling 
for primary dyslipidemia (Wiegman et al., 2015), a complex 
disease estimated to affect 2%–3% of the adult population. 
However, in Spain and many other countries, these services 
are not offered for severe psychiatric diseases that affect a 
similar range of people and impose a serious burden on pa-
tients and society, at least in a generalized manner. The main 
reason for not offering genetic counseling regarding psychi-
atric disorders in Catalonia is the lack of specific regulation. 
Several other factors may be involved in this situation. For 
example, only approximately 20% of psychiatrists consider 
themselves competent to provide genetic information to pa-
tients (Finn et al., 2005; Venugopal, Ranjith, & Issac, 2000), 
although most psychiatrists feel that they should provide such 
information (Jenkins & Arribas‐Ayllon, 2016). Psychiatrists 
and other mental health professionals report the need to im-
prove their knowledge and skills in psychiatric genetics and 
even report that a genetic counseling service that accounts for 
the complexity of psychiatric conditions (uncertainty of psy-
chiatric diagnoses, patient engagement, and a limited capacity 
to understand) is necessary and effective (Jenkins & Arribas‐
Ayllon, 2016; Moldovan et al., 2017). On the other hand, no 
valid, high‐certainty diagnostic psychiatric genetic tests are 
currently available for common complex psychiatric disorders. 
In this sense, psychiatric genetic counseling and psychiatric 
testing are considered emerging disciplines in Europe, and ef-
forts to develop a framework to facilitate the implementation 
of both disciplines into routine clinical care are currently un-
derway (https ://www.cost.eu/actio ns/CA17130).
In this context, we developed two questionnaires, one di-
rected at psychiatric health professionals and another directed at 
patients and relatives, to survey their opinions about the genetics 
of psychiatric disorders and to explore the possible demand for 
a genetic counseling service focused on psychiatric disorders.
2 |  SUBJECTS AND METHODS
2.1 | Sample and setting
The survey was conducted in the province of Tarragona 
in southern Catalonia, Spain. This area had a population of 
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800,962 in 2014 and a total area of 6,308 km2, with a relative 
population density of 127 habitants per km2 and an economic 
output of €29,400 GDP per capita. Our institution provides all 
public mental health care in this region through a network of 
community and hospitalization centers, with patients ranging 
from infants to elderly people; further details can be found in 
Gaviria et al. (2015). The study was approved by the Clinical 
Research Committee of the Hospital Universitari Institut Pere 
Mata. Participation in the survey was voluntary, and the par-
ticipation procedure was designed in such a way that it was 
completely anonymous and therefore did not require the re-
quest for written informed consent and approval by the Ethical 
Committee. No compensation was offered for participation.
2.1.1 | Professional sample
We sent the survey by institutional e‐mail to all 723 profes-
sionals, including psychiatrists, general practitioners, neurol-
ogists, psychologists, mental health nurses, clinical assistants, 
social care workers, social educators, occupational therapists, 
and other health professionals. The e‐mail contained a link to 
an online questionnaire prepared with the Cardiff TeleformR 
System (Electric Paper GmbH, Lachen, Switzerland). The 
completed questionnaire was automatically sent to a server 
and incorporated into the study database in an anonymous 
form.
2.1.2 | User sample (Patients and Relatives)
In 2015, 16,372 people had at least one clinical checkup in 
our institution: 11,024 in adult mental health centers, 4,651 
in child and adolescent mental health centers, and 697 in the 
center for people with both psychiatric disorder and intel-
lectual disability. Paper questionnaires, which were prepared 
to be automatically read with the Cardiff TeleformR System, 
were left in specific trays of the waiting rooms of seven adult 
and seven child and adolescent mental health service centers 
and in the mental health with intellectual disability commu-
nity center, and were distributed throughout the territory. Near 
the trays, flyers and posters explaining the nature and aim of 
the survey were displayed. Appropriate and identifiable bal-
lot boxes were available to deposit the anonymous question-
naires. The research team refilled the trays weekly with paper 
questionnaires for the entire recruitment period (5 months), 
and a total of 1,500 questionnaires were distributed.
2.2 | Procedures
2.2.1 | Instruments
Two survey instruments were designed by academic and clin-
ical experts in psychiatry and psychiatric genetics addressing 
three domains of interest: sociodemographic data, knowledge 
about the genetics of psychiatric diseases, and the utility of a 
psychiatric specialized genetic counseling unit. Two identi-
cal questions were addressed to both professionals and users. 
The specific questions were “To what extent do you think 
psychiatric disorders have a genetic basis?” and “To what 
extent do you think that a genetic counseling service would 
be useful?” We also asked professionals about their opinions 
on the genetic basis of specific common psychiatric disor-
ders and intellectual disability, the level of education in the 
genetics of psychiatric disorders, and whether they discuss 
genetic questions about psychiatric disorders with users. We 
also asked users whether they were worried about transmit-
ting a disease to children and whether they talk about genetic 
concerns with their relatives or mental health professionals. 
The instruments were written in both Catalan and Spanish, 
and the English versions were produced only to be shown 
here. Two members of the research team that conducted the 
survey translated the Catalan/Spanish questionnaires into 
English and two independent researchers from our group, but 
not members of the survey research team back translated the 
English questionnaires into Catalan/Spanish. No discrepan-
cies were observed between the two versions.
The professional questionnaire (Figure S1) consisted of 
eight questions regarding genetics in mental health, and the 
respondents indicated their agreement with each item on a 
10‐point Likert scale ranging from 0 (never or not at all) to 
10 (almost always or extremely). Moreover, age, sex, work 
setting, and job title were collected, together with the respon-
dents’ reports of the diagnoses of patients who they most fre-
quently helped.
The user questionnaire (Figure S2) consisted of five ques-
tions rated on a 10‐point Likert scale similar to that for the 
professional questionnaire. In addition to age and sex, partic-
ipants were asked whether they were psychiatric patients or 
relatives of psychiatric patients, their education level, and the 
number of affected relatives and their diagnoses.
2.3 | Data analysis
Descriptive statistics were obtained from the total sample and 
from the subgroups of participants and were calculated using 
percentages, means, and standard deviations. Statistical tests 
were used not to test hypothesis, but to explore the possible 
effect of age, sex, setting, career field, or education in the 
responses. Chi‐square tests were used to compare categorical 
variables with Yale's continuity correction if appropriate, and 
Mann–Whitney U tests and Kruskal–Wallis tests were used 
for numeric variables. ANOVA was used to compare item 
responses between different age groups. The normality of 
the distributions of continuous variables was explored using 
Kolmogorov–Smirnov normality tests.
Questions with answer options between 1 and 10 were cat-
egorized to facilitate interpretation of the results. To recode 
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the answers, the following categorization was performed: 0 
(never or not at all), 1–3 (seldom or slightly), 4–6 (sometimes 
or moderately), 7–9 (often or very), and 10 (almost always or 
extremely). Ratings ≥7 were considered “positive answers,” 
and ratings ≤3 were considered “negative answers”; ratings 
between 4 and 6 were considered neither positive nor nega-
tive. Analyses completed with the original codification sys-
tem ranging from 0 to 10 and with the recoded data showed 
similar results.
The professional sample was stratified by sex (male/
female), ranked age (20–35, 36–45, 45–55, 56–65, 
and >65 years), career field (children and adolescents, adults, 
intellectual disability, and geriatrics), and profession (psychi-
atrist, psychologist, mental health nurse, social care worker, 
social educator, occupational therapist, other medical spe-
cialties, administrative staff, and others). The user sample 
was stratified by sex (male/female), ranked age (≤18, 19–35, 
36–45, 46–65, and  >65  years), who completed the survey 
(patient/relative) and educational level (primary, secondary, 
and upper secondary vs postsecondary school, bachelor, or 
equivalent).
All statistical analyses were performed using IBM SPSS 
Statistics for Windows, Version 23.0 (IBM Corp., Armonk, 
NY). Graphs to represent the results were created with Prism, 
Version 5 (GraphPad, La Jolla, CA).
3 |  RESULTS
We obtained 152 and 959 valid questionnaires from profes-
sionals and users, respectively, which represented 21% of the 
invited professionals and 64% of the questionnaires delivered 
to users (Figure 1). Interestingly, most of the respondents, in-
cluding 78% of professionals and 67% of users, were women. 
Table 1 shows the sociodemographic features of the survey 
participants. Participants ≤45 years old represented 76% of 
the professionals and 53% of the users. Psychiatrists, psy-
chologists, and mental health nurses accounted for 64% of the 
professional participants according to job title. Regarding the 
users, 63% were patients and 37% were relatives of patients. 
Among the patients, 5% were younger than 18 years, 7% were 
older than 65 years, and 88% were between 18 and 55 years 
old. Sixty‐nine percent of the users who participated in the 
survey had either a primary or secondary education, which is 
usually completed at the age of 16 in Spain, while 22% had 
obtained a university education.
3.1 | Questions addressed to both 
professionals and users
Two identical questions were addressed to both professionals 
and users. Regarding the question, “To what extent do you 
think psychiatric disorders have a genetic basis?,” the aver-
age rating of professionals was 6.3 ± 1.9 (Figure 2). Although 
61% of them believed that psychiatric disorders have a ge-
netic basis (rated ≥ 7), 9.1% thought that psychiatric disor-
ders do not have or rarely have a genetic basis (rated ≤ 3). 
The extent to which professionals felt that a genetic basis for 
psychiatric disorders exists was not significantly associated 
with job title or clinical setting. Higher ratings were obtained 
with increasing age, but no significant differences were ob-
served (p = 0.234). Female professionals rated this question 
higher compared to male professionals (p = 0.023). For the 
same question regarding the genetics of psychiatric disor-
ders, the average rating for users was 5.9 ± 2.6 (Figure 2), 
which is similar to the rating of 6.3 ± 2.0 observed among 
professionals (p = 0.106). Almost half of the users, 47%, be-
lieved that psychiatric disorders are often or almost always 
related to genetics (rated ≥ 7). At the opposite pole, 5% of 
users thought that psychiatric disorders do not have a genetic 
basis at all (rated 0). Similar to professionals, the user group 
aged 36–55  years showed higher ratings for this question 
compared to the other age groups (p < 0.001). Additionally, 
patients and relatives with the highest level of education (uni-
versity studies) provided the highest ratings for this question 
(p = 0.038).
Regarding the second question addressed to both pro-
fessionals and users, “To what extent do you think that 
a genetic counseling service would be useful?,” 59% of 
professionals believed that having a genetic counseling 
unit would be very or extremely useful (rated ≥ 7), while 
only 16% thought that it would seldom or never be useful 
(rated ≤ 3) (Figure 2). Interestingly, 80% of users thought 
that a genetic counseling unit would be very or extremely 
useful. Notably, 45% of users rated this question at the max-
imum value (10), while only 2% thought that having a ge-
netic counseling service would be useless (Figure 2). Users 
rated the usefulness of a genetic counseling service ques-
tion higher than professionals, 8.1 ± 2.5 versus 5.4 ± 2.8, 
respectively (p < 0.001). The youngest professionals, those 
aged 20–35 years, rated this question higher than the old-
est professionals (p = 0.048), with higher ratings associated 
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T A B L E  1  Characteristics of the participants in the survey
Professionals N (%) Users (63% patients, 37% relatives) N (%)
Sex Sex
Male 34 (22.4) Male 307 (32.7)
Female 118 (77.6) Female 631 (67.3)
Age, y     Age, y    
      <18 51 (5.3)
20–35 53 (34.9) 18–35 188 (19.6)
36–45 63 (41.4) 36–45 265 (27.6)
46–55 29 (19.1) 46–55 262 (27.3)
56–65 7 (4.6) 56–65 130 (13.6)
      >65 63 (6.6)
Setting Setting
Child–Adolescent 25 (16.4) Child–Adolescent 166 (17.3)
Adult 81 (53.3) Adults 504 (52.6)
Intellectual disability 31 (20.4) Intellectual disability 14 (1.4)
Psychogeriatrics 15 (9.9) Mixed, child and adult 275 (28.7)
Career field Education
Psychiatrist 36 (23.7) Primary school, unfinished 101 (10.5)
Psychologist 35 (23.0) Primary school 246 (25.7)
Mental health nurse 26 (17.1) Secondary school, unfinished 75 (7.8)
Social worker 16 (10.5) Secondary school 239 (24.9)
Occupational therapist 2 (1.3) Upper secondary school 87 (9.1)
Social educator 6 (4.0) Bachelor or equivalent 211 (22.0)
Other 31 (20.4)      
F I G U R E  2  Distributions of the 
responses obtained from professionals 
and users to the two identical questions 
presented to both groups. Participant ratings 
ranged from 0 (never or not at all) to 10 
(almost always or extremely), which are 
presented on the X‐axis. The Y‐axis shows 
the percentages of participants who provided 
each rating
To what extent do 
you think that 
psychiatric
disorders have a 
genetic basis?
To what extent do 
you think that a 
genetic counseling 
service would be 
useful?
Professionals Users
























Х ≥ S.D.= 6.3 ≥ 1.9
Х ≥ S.D.= 5.4 ≥ 2.8
Х ≥ S.D.= 5.9 ≥ 2.6





(-)       Genetic basis       (+) (-)       Genetic basis       (+)
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3.2 | Questions addressed to professionals
Professionals were asked about issues focusing on the knowl-
edge and worries that users discuss with them regarding the 
genetic basis of their illnesses. Approximately 12% of pro-
fessionals provided a rating of ≥7 (often or almost always) 
for the question, “How often have patients raised questions 
about the genetics of their disorder?” On a similar ques-
tion regarding relatives instead of patients, the percentage 
of professionals who gave a rating ≥7 was 20% (Figure 3). 
Female professionals tended to rate the frequency of patients 
asking them about the genetic basis of their disease higher 
(p = 0.039). Likewise, higher ratings were provided by pro-
fessionals working in adult mental health centers (p < 0.001) 
and from psychologists (p = 0.016) compared to other groups 
in the same category. Regarding the concern of transmitting 
a disease to offspring, 19% of professionals stated that pa-
tients often or almost always (rated ≥ 7) asked them about 
this issue. On the other hand, 59% of the professionals be-
lieved that they had a low level (rated ≤ 3) of education on 
the genetics of psychiatric disorders (Figure 4). In fact, only 
8% reported having a high level of education on this topic 
(rated ≥ 7). The average rating of all professionals for this 
question was 3.2 ± 2.4. The stratified analysis revealed that 
psychiatrists rated this question higher compared to other 
professionals, with a mean rating of 4.9  ±  1.9; the other 
mean scores were 3.7 ± 4.3 for psychologists, 2.0 ± 1.8 for 
nurses, and 2.0 ± 1.2 for social workers (p = 0.007) (Figure 
4). Regarding the possibility of sending patients to a genetic 
counseling unit, 41% of professionals indicated that they 
would often or almost always send patients to such a unit 
(rated ≥ 7) compared to 27% who reported that they would 
seldom or never send patients to such a unit (rated ≤ 3).
3.3 | Questions addressed to users
Regarding the question, “How often has your psychiatrist 
talked to you about the genetics of your disorder?,” 14% re-
ported often or almost always (rated ≥ 7). Remarkably, 36% 
of users responded that their psychiatrists had never (rated 
0) talked about this issue, and 30% reported that their psy-
chiatrists rarely addressed this issue (rated between 1 and 
3) (Figure 3). Therefore, 66% of users have seldom or never 
talked about the genetics of their illnesses with their psychia-
trists (rated  ≤  3). Regarding the question, “How often has 
your family raised questions about the genetics of the disor-
der?,” 30% reported often or almost always (rated ≥ 7), but 
25% of the users had never (rated 0) talked about this issue. 
Differences were observed based on age: users aged 18–35 
responded that psychiatrists talked with them about genet-
ics more frequently compared to older subjects (p = 0.017). 
In addition, women gave higher ratings compared to men 
F I G U R E  3  Distributions of the 
responses obtained from professionals 
and users to different questions in the 
questionnaires. Participant ratings ranged 
from 0 (never or not at all) to 10 (almost 
always or extremely), which are presented 
on the X‐axis. The Y‐axis shows the 
percentages of participants who provided 
each rating












How often have patients raised questions about 
the genetics of their disorder?
How often have relatives of your patients raised 
questions about the genetics of the disorder?
How often have patients raised their concerns 
about transmitting the disease to their offspring?
How often has your psychiatrist talked to you 
about the genetics of your disorder?
Professionals Users












Х ≥ S.D.= 2.9 ≥ 2.5
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the genetics of the disorder?
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(p = 0.001). Regarding the concern of transmitting an illness 
to offspring, 43% of users reported that they have often or 
almost always been concerned about this issue, and 19% were 
almost always concerned (rated 10). Notably, however, 39% 
of users have rarely or never been concerned about this topic 
(rated ≤ 3). The diagnoses reported by users to be present in 
their family members are shown in Table 2.
4 |  DISCUSSION
The present study found that in our setting, a considerable 
number of professionals and users believe that psychiatric dis-
orders have a genetic basis; however, users of mental health 
centers do not often comment on or discuss with psychiatrists 
the genetic basis of the psychiatric disorders with which they 
have been diagnosed. Similar data were obtained when ask-
ing both psychiatrists and users. Remarkably, a considerable 
number of users reported that their psychiatrist never talked to 
them about the genetics of their illness. This finding contrasts 
with the findings that nearly half of users have often or almost 
always been concerned with transmitting a disease to their 
offspring, and that a considerable number of users, almost 
one‐third, reported that questions about the genetics of the 
disease have arisen often or almost always within their fami-
lies. Thus, our results indicate that this topic is not addressed 
in psychiatrists’ consultations despite patients’ concerns. 
Genetic factors are relevant to the etiology of most psychiat-
ric disorders. It the information age, patients can be expected 
to want to know the causes of their illnesses. Therefore, in 
F I G U R E  4  Self‐reported level of 
education regarding the genetic basis of 
psychiatric disorders by distinct professional 
profiles. Participant ratings ranged from 0 
(never or not at all) to 10 (almost always 
or extremely), which are presented on the 
X‐axis. The Y‐axis shows the percentage of 
participants who provided each rating
































( - )       Education level       ( + ) ( - )       Education level       ( + )
( - )       Education level       ( + ) ( - )       Education level       ( + )
T A B L E  2  Diagnoses indicated by users, patients (N = 604), and 
relatives (N = 335), to be present in their family members
Diagnosis
Patients Relatives
N (%) N (%)
Schizophrenia 108 (18) 54 (16)
Bipolar disorder 120 (20) 57 (17)
Major depressive 
disorder
156 (26) 57 (17)
Autism spectrum 
disorder
18 (3) 55 (16)
Obsessive compul-
sive disorder




66 (11) 89 (26)
Anxiety disorder 269 (45) 104 (30)
Behavior disorder 62 (10) 56 (16)
Personality disorder 107 (18) 40 (12)
Adaptive disorder 47 (8) 26 (8)
Addictive disorder 55 (9) 25 (7)
Intellectual disability 25 (4) 48 (14)
8 of 11 |   MARTORELL ET AL.
daily clinical practice, patients can be expected to ask about 
and discuss the etiology of their diseases with physicians, es-
pecially given that most of the professionals in our setting are 
aware of the genetic basis of psychiatric disorders. However, 
the results of the present survey were not consistent with this 
expectation and allowed us to speculate about possible expla-
nations. On the one hand, knowledge of psychiatric genetics 
has increased substantially over the last decade, and these re-
cent advances, along with the complexity of the genetic basis 
of psychiatric disorders, may lead professionals to avoid talk-
ing in depth with patients, particularly when a considerable 
amount of time may be necessary to appropriately address 
this subject. On the other hand, other factors may render this 
topic difficult to discuss, including the presence of clinical 
and genetic heterogeneity, comorbidity with some neurologi-
cal conditions in a considerable number of cases, and the 
large number of genes and types of genetic variants involved. 
Finally, environmental factors play an important role in the 
etiology of psychiatric disorders, and large differences in 
genetic and environmental factors between psychiatric disor-
ders have been reported, thus complicating the determination 
of their etiological roles (Pettersson et al., 2019). Obviously, 
the lack of a genetic counseling unit to which patients can 
be referred is also a disadvantage when discussing the ge-
netic and environmental contributors to the etiology of ill-
nesses with patients. Experienced genetic counselors agree 
on the necessity of equipping health‐care professionals with 
current knowledge of psychiatric genetics/genomics and, 
moreover, effectively communicating these aspects with pa-
tients, especially when genetic testing is performed (Hoang, 
Cytrynbaum, & Scherer, 2018). Therefore, genetic counse-
lors must be trained in the genetic basis of psychiatric dis-
orders. In this sense, extensive insight can be gained from 
the experiences of the world's first genetic counseling ser-
vice in psychiatry in Vancouver, with professionals who have 
treated more than 500 families and demonstrated the benefits 
of this service in terms of patient empowerment and self‐ef-
ficacy after attending genetic counseling (Inglis et al., 2015). 
This service has recently reported interest among users in a 
prenatal context in knowing the likelihood of their children 
developing an illness present in the family (Borle, Morris, 
Inglis, & Austin, 2018) and how they can address this issue 
with prenatal genetic counseling (Inglis, Morris, & Austin, 
2017). The authors showed that this context also serves as 
an opportunity to engage patients and to help them feel em-
powered. Ideally, this training should be generalized to other 
mental health providers, especially psychiatrists, who are in 
contact with users, either patients or relatives. Accordingly, 
the International Society of Psychiatric Genetics recently re-
ported that informed genetic counseling in psychiatry is in 
greater demand than ever and recommends that genetic edu-
cation should become an integral part of psychiatric training 
(Nurnberger et al., 2018).
Analytically and clinically valid genetic tests for neu-
rodevelopmental disorders, including Fragile X syndrome, 
Down's syndrome, and neurodegenerative diseases such as 
Huntington's disease are available. Therefore, genetic coun-
seling can be offered to screen at‐risk individuals before the 
onset of symptoms, before clinical diagnosis, or to establish 
the diagnosis after symptoms have appeared. However, an es-
timated 30 million Europeans are related to patients affected 
by genetic conditions that may have been underrecognized 
by the health system. This finding contravenes the European 
Union's aim to create safe, efficient, patient‐centered, and 
sustainable health‐care systems (McAllister, Moldovan, 
Paneque, & Skirton, 2016). In fact, the global number of 
genetic counselors has been estimated to be small, although 
genetic counseling is considered a growing area (Abacan et 
al., 2019; Cordier, Lambert, Voelckel, Hosterey‐Ugander, & 
Skirton, 2012; Ormond et al., 2018). The situation is much 
worse for psychiatric disorders. Genetic counseling services 
do not routinely provide assistance to patients with psychiatric 
disorders, although we currently know that several recurrent 
CNVs can confer a substantial risk for ASD, SCH, epilepsy, 
developmental delays, and congenital malformations (Kirov et 
al., 2014). Although CNVs have been implicated in these dis-
orders, CNV genetic analysis is usually recommended only for 
children (Jeste & Geschwind, 2014; Schaefer, Mendelsohn, 
& Professional Practice and Guidelines Committee, 2013). 
Regarding ASD, a recent study has explored access to ge-
netic counseling in six ASD family associations in Catalonia, 
a geographical area that includes our province. The authors 
identified extensive underutilization of this service, with only 
30% of all families receiving a genetic service and only 13% 
of patients undergoing genetic screening as recommended 
(Codina‐Solà, Pérez‐Jurado, Cuscó, & Serra‐Juhé, 2017). 
Indeed, at least in Catalonia, adult patients affected by psychi-
atric disorders with onset in adolescence or adulthood, such 
as schizophrenia, are not genetically screened, although these 
recurrent risk CNVs have been estimated to be present in 2.5% 
of schizophrenia patients (Kirov et al., 2014; Rees et al., 2011). 
In addition to the interest that patients may have in accessing 
genetic tests, especially patients with schizophrenia, genetic 
counseling may play an important role within the framework 
of psychiatric/psychotherapeutic treatment because genetic 
testing has psychological, ethical, and clinical implications, 
as indicated in the “Genetic Testing Statement” published by 
the Genetic Testing Working Group from the International 
Society of Psychiatric Genetics (https ://ispg.net/genet ic-testi 
ng-state ment/).
Finally, female professionals and users are more aware 
and concerned about the genetics of psychiatric disorders 
compared to males. Female professionals also reported a 
higher likelihood of discussing genetics with patients com-
pared to male professionals. Among the reasons that may 
explain these gender differences, women may have stronger 
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association with reproduction; therefore, patients feel that 
questions about inheritance may be more appropriate for 
women versus men. Another reason may be that women 
professionals may be more empathetic and thus relatable. 
Therefore, the gender perspective must be considered, and 
this issue should be included in future training programs and 
addressed appropriately.
The strength of this study is the large number of mental 
health users who participated. However, several limitations 
should be mentioned, including the relatively small num-
ber of professionals who participated in the study consider-
ing the number of professionals working in our institution. 
Additionally, the study was conducted in a province with 
only one public mental health provider with a research group 
devoted to studying the genetic basis of psychiatric disor-
ders, which may have influenced the results of the survey. 
Although our data were collected from a single province in 
Spain, these results are likely generalizable to most regions in 
developed countries.
In summary, the benefits of genetic counseling even with-
out genetic testing have been demonstrated. In addition, evi-
dence supports the contributions of SNPs, CNVs, and RCVs 
to the development of psychiatric disorders. In some cases, the 
genetic component of a psychiatric disease is highly heritable 
within a family; however, in a significant number of cases, 
the genetic variant has occurred in the germ line and manifest 
as a de novo mutation. Therefore, people suffering from a 
psychiatric disorder with high heritability, namely, SCH or 
ASD, should visit a genetic counseling unit, at least during 
the reproductive period. Likewise, families with psychiatric 
illness aggregation should also be evaluated. Finally, in addi-
tion to these two approaches focusing on high heritability and 
high aggregability, the relatively high number of CNVs that 
occur as de novo mutations justifies screening for this type of 
mutation, at least in all severe psychiatric patients, especially 
when present with comorbid conditions. Performing more 
tests and uploading more data in specific databases will in-
crease the usefulness of the genetic screening and counseling. 
In this sense, uploading genetic information as well as pheno-
typical and environmental data that would translate from the 
clinical to research settings would be helpful.
The results of the present study showed that both profes-
sionals and users are aware of the genetic basis of psychiatric 
disorders, and both believe that access to a genetic counseling 
service would be very useful. Notably, although they did not 
report asking their psychiatrists about the genetics of psy-
chiatric disorders, most patients were concerned about these 
issues and are interested in psychiatric genetic counseling.
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